Keywords: collagenex, revenues, up, first, quarter, usa, pharmaceuticals
CollaGenex revenues up 53% in first quarter
Article | 29 April 2002
The USA's CollaGenex Pharmaceuticals has posted revenues of $10.8million for the first quarter of 2002, representing a 53% increase compared to the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
